Gamaleya Center submits documents to Russian Health Ministry for registering coronavirus vaccine for teens
MOSCOW. Sept 23 (Interfax) - The Gamaleya Center has submitted documents to the Russian Health Ministry in order to register a coronavirus vaccine for teens, the Russian health minister's assistant Alexei Kuznetsov said on Thursday.
"Yes, we have received a package of documents for registering a coronavirus vaccine for teenagers," Kuznetsov told Interfax in response to the relevant question.
Clinical trials of the Sputnik V (Gam-COVID-Vac-M) coronavirus vaccine for children aged from 12 to 17 began in Moscow on July 2. The trial is taking place at two children's medical institutions: the Bashlyayeva Hospital and the Morozov Hospital.
Russia is using four vaccines for mass vaccination for Covid-19; these are Sputnik V and Sputnik Light developed by the Russian Health Ministry's Gamaleya Center, EpiVacCorona developed by the Vector Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), and CoviVac developed by the Chumakov Institute of the Russian Academy of Sciences. Clinical trials of the EpiVacCorona vaccine on teens aged from 15 to 17 might begin in the near future, as the trials on adult subjects come to an end, Vector Center head Rinat Maksyutov said.